Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

ApoGen Biotechnologies

ApoGen Biotechnologies is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.

Overview Structured Data Issues Contributors Activity

apogenbiotech.com

Is a

Organization

Company

Company attributes

Industry

...

Location

Founder

Pitchbook URL

pitchbook.com/profiles...150156-64

Email Address

info@apogenbiotech.com0

Phone Number

+120695773000

Full Address

2815 Eastlake Avenue East, Suite 300 Seattle, WA 981020

Investors

Lilly Ventures

Alexandria Venture Investments

WuXi AppTec

‌

Watson Fund

ARCH Venture Partners

WRF Capital

AbbVie Inc.

Fax Number

+120695773990

Total Funding Amount (USD)

7,000,000

Latest Funding Round Date

December 13, 2016

Latest Funding Type

Series A

Country

United States

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like ApoGen Biotechnologies

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API